Circulating monocyte subsets and heart failure prognosis.

Circulating monocyte subsets and heart failure prognosis.

Monocytes are a heterogeneous population of effector cells with key roles in tissue integrity restoration and maintenance. Here, we explore the association of monocyte subsets and prognosis in patients with ambulatory heart failure (HF). Monocyte subsets were classified as classical (CD14++/CD16-),...

Full description

Bibliographic Details
Main Authors:	Elena Elchinova, Iris Teubel, Santiago Roura, Marco A Fernández, Josep Lupón, Carolina Gálvez-Montón, Marta de Antonio, Pedro Moliner, Mar Domingo, Elisabet Zamora, Julio Núñez, Germán Cediel, Antoni Bayés-Genís
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2018-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC6150659?pdf=render

Similar Items

Telomere attrition in heart failure: a flow-FISH longitudinal analysis of circulating monocytes
by: Iris Teubel, et al.
Published: (2018-02-01)

Circulating neprilysin hypothesis: A new opportunity for sacubitril/valsartan in patients with heart failure and preserved ejection fraction?
by: Josep Lupón, et al.
Published: (2021-01-01)

Biomarkers in Heart Failure with Preserved Ejection Fraction
by: Antoni Bayes-Genis, et al.
Published: (2022-06-01)

Mesenchymal Stem Cells Induce Expression of CD73 in Human Monocytes In Vitro and in a Swine Model of Myocardial Infarction In Vivo
by: Marta Monguió-Tortajada, et al.
Published: (2017-11-01)

Mortality Risk Prediction Dynamics After Heart Failure Treatment Optimization: Repeat Risk Assessment Using Online Risk Calculators
by: Pau Codina, et al.
Published: (2022-04-01)

Predictive biomarkers for death and rehospitalization in comorbid frail elderly heart failure patients
by: Cristina Pacho, et al.
Published: (2018-05-01)

Epigenetic Biomarkers in Cardiovascular Diseases
by: Carolina Soler-Botija, et al.
Published: (2019-10-01)

Mesenchymal stem cells for cardiac repair: are the actors ready for the clinical scenario?
by: Santiago Roura, et al.
Published: (2017-10-01)

Electrophysiological effects of adipose graft transposition procedure (AGTP) on the post-myocardial infarction scar: A multimodal characterization of arrhythmogenic substrate
by: Raquel Adeliño, et al.
Published: (2022-09-01)

Quality of life in patients with heart failure and improved ejection fraction: one‐year changes and prognosis
by: Elisabet Zamora, et al.
Published: (2022-12-01)

First-in-man Safety and Efficacy of the Adipose Graft Transposition Procedure (AGTP) in Patients With a Myocardial Scar
by: Antoni Bayes-Genis, et al.
Published: (2016-05-01)

Decoding empagliflozin’s molecular mechanism of action in heart failure with preserved ejection fraction using artificial intelligence
by: Antoni Bayes-Genis, et al.
Published: (2021-06-01)

Nutritional Status According to the GLIM Criteria in Patients with Chronic Heart Failure: Association with Prognosis
by: Clara Joaquín, et al.
Published: (2022-05-01)

Mortality trends in an ambulatory multidisciplinary heart failure unit from 2001 to 2018
by: Giosafat Spitaleri, et al.
Published: (2021-01-01)

Cause of Death in Heart Failure Based on Etiology: Long-Term Cohort Study of All-Cause and Cardiovascular Mortality
by: Giosafat Spitaleri, et al.
Published: (2022-01-01)

Lung ultrasound in outpatients with heart failure: the wet‐to‐dry HF study
by: Mar Domingo, et al.
Published: (2021-12-01)

Prognostic Value of New‐Generation Troponins in ST‐Segment–Elevation Myocardial Infarction in the Modern Era: The RUTI‐STEMI Study
by: Germán Cediel, et al.
Published: (2017-12-01)

Weight Loss in Obese Patients With Heart Failure
by: Elisabet Zamora, et al.
Published: (2016-03-01)

Circulating Monocyte Subsets and Transcatheter Aortic Valve Replacement
by: Fanny Lassalle, et al.
Published: (2022-05-01)

Lung ultrasound and biomarkers in primary care: Partners for a better management of patients with heart failure?
by: Mar Domingo, et al.
Published: (2020-10-01)

Long-term LVEF trajectories in patients with type 2 diabetes and heart failure: diabetic cardiomyopathy may underlie functional decline
by: María Teresa Julián, et al.
Published: (2020-03-01)

Transitioning from Preclinical to Clinical Heart Failure with Preserved Ejection Fraction: A Mechanistic Approach
by: Antoni Bayes-Genis, et al.
Published: (2020-04-01)

Sacubitril/valsartan affects pulmonary arterial pressure in heart failure with preserved ejection fraction and pulmonary hypertension
by: Pau Codina, et al.
Published: (2022-08-01)

Importance of iron deficiency in patients with chronic heart failure as a predictor of mortality and hospitalizations: insights from an observational cohort study
by: José González-Costello, et al.
Published: (2018-11-01)

The Association of Lipoprotein(a) and Circulating Monocyte Subsets with Severe Coronary Atherosclerosis
by: Olga I. Afanasieva, et al.
Published: (2021-06-01)

The Potential Anti-remodeling Effect of Paroxetine After Myocardial Infarction May Be Blunted by Beta-Blockers
by: Oriol Iborra-Egea, et al.
Published: (2022-07-01)

Vaccination with MVA/HIV induces differential recruitment of monocyte subsets into the circulation and monocyte-specific transcriptional programs
by: Andersen-Nissen E, et al.
Published: (2012-09-01)

Mechanisms of action of sacubitril/valsartan on cardiac remodeling: a systems biology approach
by: Oriol Iborra-Egea, et al.
Published: (2017-04-01)

The Ontogeny of Monocyte Subsets
by: Anja A. Wolf, et al.
Published: (2019-07-01)

Preclinical scenario of targeting myocardial fibrosis with chimeric antigen receptor (CAR) immunotherapy
by: Gemma Ferrer-Curriu, et al.
Published: (2023-02-01)

Circulating virome and inflammatory proteome in patients with ST-elevation myocardial infarction and primary ventricular fibrillation
by: Teresa Oliveras, et al.
Published: (2022-05-01)

Circulating Monocyte Subsets Are Associated With Extent of Myocardial Injury but Not With Type of Myocardial Infarction
by: Noushin Askari, et al.
Published: (2021-11-01)

Human umbilical cord blood-derived mesenchymal stem cells promote vascular growth in vivo.
by: Santiago Roura, et al.
Published: (2012-01-01)

Serum Neprilysin and Recurrent Admissions in Patients With Heart Failure
by: Julio Núñez, et al.
Published: (2017-08-01)

Monocyte subsets and monocyte-related chemokines in Takayasu arteritis
by: Mariana Freitas de Aguiar, et al.
Published: (2023-02-01)

Fatty Acid Binding Proteins 3 and 4 Predict Both All-Cause and Cardiovascular Mortality in Subjects with Chronic Heart Failure and Type 2 Diabetes Mellitus
by: Ricardo Rodríguez-Calvo, et al.
Published: (2023-03-01)

Heart Failure Treatment by Device
by: Antoni Bayés-Genis
Published: (2020-04-01)

The DELIVER Trial: The Beginning of the End of Ejection Fraction Tyranny
by: Antoni Bayes-Genis
Published: (2022-12-01)

Destination Therapy with Left Ventricular Assist Devices in Non-transplant Centres: The Time is Right
by: Antoni Bayes-Genis, et al.
Published: (2020-04-01)

Identification of temporal and region-specific myocardial gene expression patterns in response to infarction in swine.
by: Cristina Prat-Vidal, et al.
Published: (2013-01-01)